1 active not recruiting, 1 completed, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Cancer of Colon: new trials by email Literature Review of Cancer of Colon trials Research Report on Cancer of Colon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations HBI-2376 - Non Small Cell Lung Cancer, Colorectal Cancer | Phase 1 | Active not recruiting | HUYABIO International, LLC. | 42 | 2021-12-13 | 2025-09-24 |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver | Phase 1 / Phase 2 | Unknown | Leaf Vertical Inc. | 160 | 2019-01-15 | 2018-07-31 |
| Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) FOLFOX6, EGFRBi armed ATC Infusions - Colorectal Cancer, Cancer of Pancreas | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 15 | 2011-08-17 | 2023-05-06 |
Colonic Neoplasms (3) · Pancreatic Neoplasms (3) · Colorectal Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Gallbladder Neoplasms (1) · Glioblastoma (1) · Liver Neoplasms (1) · Multiple Myeloma (1) · Neoplasms (1) · Rectal Neoplasms (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Pancreatic Diseases (3) · Rectal Diseases (3) · Neoplasms (2) · Astrocytoma (1) · Biliary Tract Diseases (1)
Fluorouracil (2) · Leucovorin (2) · Oxaliplatin (2) · Bevacizumab (1) · Bortezomib (1) · Cannabidiol (1) · Folfox protocol (1) · Gemcitabine (1) · Irinotecan (1) · Temozolomide (1)
Barbara Ann Karmanos Cancer Institute (1) · HUYABIO International, LLC. (1) · Leaf Vertical Inc. (1)
United States (3) · Puerto Rico (1)
Anthony Shields, M.D. PhD (1) · Ravi Salgia, MD (1) · Sarah F Katta, DO (1)